As of 2024-07-27, the Relative Valuation of Emergent BioSolutions Inc (EBS) is (199.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.97 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is -1527.0%.
The range of the Relative Valuation is (185.58) - (233.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 16.6x | 14.3x |
| Forward P/E multiples | 12.8x - 16.3x | 13.5x |
| Fair Price | (185.58) - (233.19) | (199.35) |
| Upside | -1428.4% - -1769.3% | -1527.0% |
| Date | P/E |
| 2024-07-26 | -0.97 |
| 2024-07-25 | -0.96 |
| 2024-07-24 | -0.96 |
| 2024-07-23 | -0.87 |
| 2024-07-22 | -0.80 |
| 2024-07-19 | -0.78 |
| 2024-07-18 | -0.80 |
| 2024-07-17 | -0.84 |
| 2024-07-16 | -0.84 |
| 2024-07-15 | -0.79 |
| 2024-07-12 | -0.74 |
| 2024-07-11 | -0.69 |
| 2024-07-10 | -0.65 |
| 2024-07-09 | -0.61 |
| 2024-07-08 | -0.57 |
| 2024-07-05 | -0.55 |
| 2024-07-03 | -0.53 |
| 2024-07-02 | -0.52 |
| 2024-07-01 | -0.49 |
| 2024-06-28 | -0.48 |
| 2024-06-27 | -0.49 |
| 2024-06-26 | -0.46 |
| 2024-06-25 | -0.48 |
| 2024-06-24 | -0.47 |
| 2024-06-21 | -0.45 |
| 2024-06-20 | -0.45 |
| 2024-06-18 | -0.42 |
| 2024-06-17 | -0.42 |
| 2024-06-14 | -0.43 |
| 2024-06-13 | -0.42 |
| 2024-06-12 | -0.44 |
| 2024-06-11 | -0.45 |
| 2024-06-10 | -0.45 |
| 2024-06-07 | -0.43 |
| 2024-06-06 | -0.44 |
| 2024-06-05 | -0.47 |
| 2024-06-04 | -0.39 |
| 2024-06-03 | -0.43 |
| 2024-05-31 | -0.40 |
| 2024-05-30 | -0.35 |
| 2024-05-29 | -0.32 |
| 2024-05-28 | -0.33 |
| 2024-05-24 | -0.33 |
| 2024-05-23 | -0.34 |
| 2024-05-22 | -0.35 |
| 2024-05-21 | -0.36 |
| 2024-05-20 | -0.40 |
| 2024-05-17 | -0.39 |
| 2024-05-16 | -0.37 |
| 2024-05-15 | -0.40 |